Clinical trial
Green Laser Photocoagulation Study in Proliferative Diabetic Retinopathy
NCT00355680 · Aurolab, Other · Completed
Key facts
| NCT number | NCT00355680 |
|---|---|
| Title | Green Laser Photocoagulation Study in Proliferative Diabetic Retinopathy |
| Official title | Comparative Study of Indigenous Green Laser With Already Available Green Laser in Proliferative Diabetic Retinopathy |
| Lead sponsor | Aurolab, Other |
| Collaborators | Raja Ramanna Centre for Advanced Technology (RRCAT) |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetic Retinopathy |
| Intervention type | Device |
| Interventions | Green Laser (Aurolas, Aurolab), Green Laser (Iridex) |
| Enrollment | 24 |
| Start date | Dec 1, 2005 |
| Primary completion | Jul 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Jul 24, 2006 |
| Last update posted | Feb 11, 2009 |
| Countries | India |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: